(NASDAQ: OMER) Omeros's forecast annual revenue growth rate of 198.55% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.07%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.06%.
Omeros's revenue in 2026 is $9,893,000.On average, 6 Wall Street analysts forecast OMER's revenue for 2026 to be $5,019,954,623, with the lowest OMER revenue forecast at $4,766,351,379, and the highest OMER revenue forecast at $5,228,395,645. On average, 5 Wall Street analysts forecast OMER's revenue for 2027 to be $10,571,144,351, with the lowest OMER revenue forecast at $7,503,876,806, and the highest OMER revenue forecast at $15,107,631,603.
In 2028, OMER is forecast to generate $19,659,317,679 in revenue, with the lowest revenue forecast at $10,078,991,937 and the highest revenue forecast at $32,358,297,467.